FDA Adverse Event Injury Summary report: N

XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 3903416 · Received June 30, 2014

Report

Report Number
2024168-2014-04236
Event Type
Injury
Date Received
June 30, 2014
Date of Event
October 29, 2013
Report Date
June 24, 2014
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ON (B)(6) 2013: CK=4134 U/L, NORMAL UPPER LIMIT 190. ON (B)(6) 2013: CK-MB=226 U/L, NORMAL UPPER LIMIT 25. ON (B)(6) 2013: TROPONIN I=50 NG/ML, UPPER REFERENCE LIMIT 0.78. CONCOMITANT MEDICAL PRODUCTS: STENT: XIENCE PRIME 3.0X28MM. OTHER: ASPIRIN, CLOPIDOGREL. THERE WAS NO REPORTED DEVICE MALFUNCTION AND THE PRODUCT WAS NOT RETURNED. THE REPORTED PATIENT EFFECT OF MYOCARDIAL INFARCTION, AS LISTED IN THE XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE (IFU), IS A KNOWN PATIENT EFFECT THAT MAY BE ASSOCIATED WITH THE USE OF CORONARY STENTS. IN THIS CASE, A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2013, THE PATIENT UNDERWENT A STENTING PROCEDURE WITH PLACEMENT OF A 2.75 X 38 MM XIENCE PRIME STENT AND A 3.0 X 28 MM XIENCE PRIME STENT IN THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD) ARTERY. ONE DAY POST PROCEDURE, THE PATIENT'S CARDIAC ENZYMES WERE ELEVATED AND A MYOCARDIAL INFARCTION WAS DIAGNOSED. MEDICATION WAS ADMINISTERED. THE PATIENT CONDITION RESOLVED ON (B)(6) 2013 AND THE PATIENT WAS DISCHARGED ON (B)(6) 2013. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
379276 XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 3021241

Patients

Seq Age Sex Outcome Treatment
1 70 YR Hospitalization| R| S SEE H10 FOR CONCOMITANT MEDICAL DEVICES